KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Operating Margin (2016 - 2025)

Historic Operating Margin for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to 34.56%.

  • Resmed's Operating Margin rose 20100.0% to 34.56% in Q4 2025 from the same period last year, while for Dec 2025 it was 33.7%, marking a year-over-year increase of 20300.0%. This contributed to the annual value of 32.75% for FY2025, which is 45800.0% up from last year.
  • Latest data reveals that Resmed reported Operating Margin of 34.56% as of Q4 2025, which was up 20100.0% from 33.43% recorded in Q3 2025.
  • Resmed's 5-year Operating Margin high stood at 34.56% for Q4 2025, and its period low was 23.66% during Q4 2023.
  • Moreover, its 5-year median value for Operating Margin was 28.99% (2021), whereas its average is 29.36%.
  • Per our database at Business Quant, Resmed's Operating Margin tumbled by -34500bps in 2023 and then surged by 88900bps in 2024.
  • Quarter analysis of 5 years shows Resmed's Operating Margin stood at 27.79% in 2021, then dropped by -2bps to 27.1% in 2022, then decreased by -13bps to 23.66% in 2023, then soared by 38bps to 32.54% in 2024, then increased by 6bps to 34.56% in 2025.
  • Its Operating Margin stands at 34.56% for Q4 2025, versus 33.43% for Q3 2025 and 33.72% for Q2 2025.